The potential of biologics for the treatment of asthma
Authors:
- Girolamo PelaiaGPGirolamo Pelaia
- Alessandro VatrellaAlessandro Vatrella
- Rosario MaselliRMRosario Maselli
- 30 November 2012
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 11 (12) , 958-972
Abstract
Recent advances in the knowledge of asthma pathobiology suggest that biological therapies that target cytokines can be potentially useful for the treatment of this complex and heterogeneous airway disease. The use of biologics in asthma has been established with the approval of the humanized monoclonal immunoglobulin E-targeted antibody omalizumab (Xolair; Genentech/Novartis) as an add-on treatment for inadequately controlled disease. Furthermore, evidence is accumulating in support of the efficacy of other biologics, such as interleukin-5 (IL-5)- and IL-13-specific drugs. Therefore, these new developments are changing the scenario of asthma therapies, especially with regard to more severe disease. The variability among patients' individual therapeutic responses highlights that it will be necessary to characterize the different asthma subtypes so that phenotype-targeted treatments based on the use of biologics can be implemented.Keywords
This publication has 146 references indexed in Scilit:
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- Asthma outcomes: BiomarkersJournal of Allergy and Clinical Immunology, 2012
- Cytokine/anti‐cytokine therapy – novel treatments for asthma?British Journal of Pharmacology, 2011
- The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammationNature Immunology, 2010
- A new look at the pathogenesis of asthmaClinical Science, 2009
- Th17 Immunity in Patients with Allergic AsthmaInternational Archives of Allergy and Immunology, 2009
- Innate Cells and T Helper 2 Cell Immunity in Airway InflammationImmunity, 2009
- Frequency of Foxp3+CD4+CD25+ T cells is associated with the phenotypes of allergic asthmaRespirology, 2009
- Effect of 17q21 Variants and Smoking Exposure in Early-Onset AsthmaNew England Journal of Medicine, 2008
- Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research ProgramJournal of Allergy and Clinical Immunology, 2007